tert-Butyl 2-oxocyclopentane-1-carboxylate

Catalog No.: 
ACXHKW763
CAS No.: 
84109-76-2
Molecular Formula: 
C10H16O3
Molecular Weight: 
184.24
tert-Butyl 2-oxocyclopentane-1-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$96.00In stockIn stock
1g95%$238.00In stockIn stock
5g95%$714.00In stockIn stock
25g95%$3561.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl 2-oxocyclopentane-1-carboxylate
IUPAC Nametert-butyl 2-oxocyclopentane-1-carboxylate
MDL No.MFCD19301646
Molecular FormulaC10H16O3
Molecular Weight184.24
SMILESO=C(C1C(CCC1)=O)OC(C)(C)C
InChI KeyOGIKPUCMXHEUMK-UHFFFAOYSA-N
Synonymtert-Butyl 2-Oxocyclopentanecarboxylate;Cyclopentanecarboxylic acid, 2-oxo-, 1,1-dimethylethyl ester;tert-Butyl 2-oxocyclopentane-1-carboxylate;tert-Butyl 2-Oxocyclopentanecarboxylate CAS:84109-76-2
CAS No.84109-76-2
PubChem CID11052317

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACXHKW763 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACXHKW763 route product structure diagram
    ACXHKW76384109-76-2In Stock
Inquiry

2. ACXHKW763 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACXHKW763 route product structure diagram
    ACXHKW76384109-76-2In Stock
Inquiry

3. ACXHKW763 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACXHKW763 route product structure diagram
    ACXHKW76384109-76-2In Stock
Inquiry

Comments (0)